Gillead had signed partnership agreements with Lily to blosterd remdesivir effectiness with combo drugs - which is very much lacking, also surppose to be talking with Austrlaina SPL for same reason.
I read a statement - on Gillead website earlier on the suggest remdesivir wasn't all that effect, unless taken very early on ..and no effect on moderate to serve case...yet gets approval- what a corrupt world we live in?!
other companies struggle to get approval for treatment that actuall work.
Big Pharma at work
- Forums
- ASX - By Stock
- MSB
- TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP, page-99
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
93.0¢ | 93.5¢ | 91.5¢ | $1.473M | 1.596M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32370 | 92.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.0¢ | 60258 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 63 | 0.945 |
3 | 49811 | 0.925 |
7 | 80943 | 0.920 |
19 | 146537 | 0.915 |
12 | 148506 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 6667 | 4 |
0.900 | 38 | 1 |
0.905 | 670 | 1 |
0.920 | 42500 | 1 |
0.930 | 50529 | 5 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |